123 related articles for article (PubMed ID: 32128793)
21. Live donor liver transplantation for patients with hepatocellular carcinoma offers increased survival vs. deceased donation.
Goldaracena N; Gorgen A; Doyle A; Hansen BE; Tomiyama K; Zhang W; Ghanekar A; Lilly L; Cattral M; Galvin Z; Selzner M; Bhat M; Selzner N; McGilvray I; Greig PD; Grant DR; Sapisochin G
J Hepatol; 2019 Apr; 70(4):666-673. PubMed ID: 30630009
[TBL] [Abstract][Full Text] [Related]
22. Survival of children after liver transplantation for hepatocellular carcinoma.
Baumann U; Adam R; Duvoux C; Mikolajczyk R; Karam V; D'Antiga L; Chardot C; Coker A; Colledan M; Ericzon BG; Line PD; Hadzic N; Isoniemi H; Klempnauer JL; Reding R; McKiernan PJ; McLin V; Paul A; Salizzoni M; Furtado ESB; Schneeberger S; Karch A;
Liver Transpl; 2018 Feb; 24(2):246-255. PubMed ID: 29222922
[TBL] [Abstract][Full Text] [Related]
23. A disease-based comparison of liver transplantation outcomes.
Mailey B; Buchberg B; Prendergast C; Artinyan A; Khalili J; Sanchez-Luege N; Colquhoun SD; Kim J
Am Surg; 2009 Oct; 75(10):901-8. PubMed ID: 19886131
[TBL] [Abstract][Full Text] [Related]
24. Outcome of ABO-incompatible adult living-donor liver transplantation for patients with hepatocellular carcinoma.
Yoon YI; Song GW; Lee SG; Hwang S; Kim KH; Kim SH; Kang WH; Cho HD; Jwa EK; Kwon JH; Tak EY; Kirchner VA
J Hepatol; 2018 Jun; 68(6):1153-1162. PubMed ID: 29452208
[TBL] [Abstract][Full Text] [Related]
25. Analysis of tumor characteristics and survival in liver transplant recipients with incidentally diagnosed hepatocellular carcinoma.
Cho CS; Knechtle SJ; Heisey DM; Hermina M; Armbrust M; D'Alessandro AM; Musat AI; Kalayoglu M
J Gastrointest Surg; 2001; 5(6):594-601; discussion 601-2. PubMed ID: 12086897
[TBL] [Abstract][Full Text] [Related]
26. Incidence and risk factors for hepatocellular carcinoma after solid organ transplantation.
Hoffmann CJ; Subramanian AK; Cameron AM; Engels EA
Transplantation; 2008 Sep; 86(6):784-90. PubMed ID: 18813102
[TBL] [Abstract][Full Text] [Related]
27. The race to liver transplantation: a comparison of patients with and without hepatocellular carcinoma from listing to post-transplantation.
Patel MS; Kohn R; Kratz JR; Shah JA; Markmann JF; Vagefi PA
J Am Coll Surg; 2015 Jun; 220(6):1001-7. PubMed ID: 25868408
[TBL] [Abstract][Full Text] [Related]
28. Diabetes mellitus may affect the long-term survival of hepatitis B virus-related hepatocellular carcinoma patients after liver transplantation.
Zhang Q; Deng YL; Liu C; Huang LH; Shang L; Chen XG; Wang LT; Du JZ; Wang Y; Wang PX; Zhang H; Shen ZY
World J Gastroenterol; 2016 Nov; 22(43):9571-9585. PubMed ID: 27920478
[TBL] [Abstract][Full Text] [Related]
29. No apparent benefit of preemptive sorafenib therapy in liver transplant recipients with advanced hepatocellular carcinoma on explant.
Satapathy SK; Das K; Kocak M; Helmick RA; Eason JD; Nair SP; Vanatta JM
Clin Transplant; 2018 May; 32(5):e13246. PubMed ID: 29577449
[TBL] [Abstract][Full Text] [Related]
30. Results of salvage liver transplantation.
Guerrini GP; Gerunda GE; Montalti R; Ballarin R; Cautero N; De Ruvo N; Spaggiari M; Di Benedetto F
Liver Int; 2014 Jul; 34(6):e96-e104. PubMed ID: 24517642
[TBL] [Abstract][Full Text] [Related]
31. A decade of right liver adult-to-adult living donor liver transplantation: the recipient mid-term outcomes.
Chan SC; Fan ST; Lo CM; Liu CL; Wei WI; Chik BH; Wong J
Ann Surg; 2008 Sep; 248(3):411-9. PubMed ID: 18791361
[TBL] [Abstract][Full Text] [Related]
32. Clinical outcomes of donation after circulatory death liver transplantation in primary sclerosing cholangitis.
Trivedi PJ; Scalera I; Slaney E; Laing RW; Gunson B; Hirschfield GM; Schlegel A; Ferguson J; Muiesan P
J Hepatol; 2017 Nov; 67(5):957-965. PubMed ID: 28690174
[TBL] [Abstract][Full Text] [Related]
33. Sirolimus Use in Liver Transplant Recipients With Hepatocellular Carcinoma: A Randomized, Multicenter, Open-Label Phase 3 Trial.
Geissler EK; Schnitzbauer AA; Zülke C; Lamby PE; Proneth A; Duvoux C; Burra P; Jauch KW; Rentsch M; Ganten TM; Schmidt J; Settmacher U; Heise M; Rossi G; Cillo U; Kneteman N; Adam R; van Hoek B; Bachellier P; Wolf P; Rostaing L; Bechstein WO; Rizell M; Powell J; Hidalgo E; Gugenheim J; Wolters H; Brockmann J; Roy A; Mutzbauer I; Schlitt A; Beckebaum S; Graeb C; Nadalin S; Valente U; Turrión VS; Jamieson N; Scholz T; Colledan M; Fändrich F; Becker T; Söderdahl G; Chazouillères O; Mäkisalo H; Pageaux GP; Steininger R; Soliman T; de Jong KP; Pirenne J; Margreiter R; Pratschke J; Pinna AD; Hauss J; Schreiber S; Strasser S; Klempnauer J; Troisi RI; Bhoori S; Lerut J; Bilbao I; Klein CG; Königsrainer A; Mirza DF; Otto G; Mazzaferro V; Neuhaus P; Schlitt HJ
Transplantation; 2016 Jan; 100(1):116-25. PubMed ID: 26555945
[TBL] [Abstract][Full Text] [Related]
34. Effects of maintenance immunosuppression with sirolimus after liver transplant for hepatocellular carcinoma.
Yanik EL; Chinnakotla S; Gustafson SK; Snyder JJ; Israni AK; Segev DL; Engels EA
Liver Transpl; 2016 May; 22(5):627-34. PubMed ID: 26784951
[TBL] [Abstract][Full Text] [Related]
35. Higher Bilirubin Levels of Healthy Living Liver Donors Are Associated With Lower Posttransplant Hepatocellular Carcinoma Recurrence.
Han S; Yang JD; Sinn DH; Ko JS; Kim JM; Shin JC; Son HJ; Gwak MS; Joh JW; Kim GS
Transplantation; 2016 Sep; 100(9):1933-8. PubMed ID: 27362316
[TBL] [Abstract][Full Text] [Related]
36. Long term outcomes of patients transplanted for hepatocellular carcinoma with human immunodeficiency virus infection.
Eman P; Chacon E; Gupta M; Berger JC; Shah MB; El Haddad HE; El-Husseini A; Dela Cruz AC; Grigorian A; Mei X; Gedaly R
HPB (Oxford); 2019 Aug; 21(8):1009-1016. PubMed ID: 30765199
[TBL] [Abstract][Full Text] [Related]
37. Transplantation versus resection for patients with combined hepatocellular carcinoma-cholangiocarcinoma.
Groeschl RT; Turaga KK; Gamblin TC
J Surg Oncol; 2013 May; 107(6):608-12. PubMed ID: 23386397
[TBL] [Abstract][Full Text] [Related]
38. Assessing Competing Risks for Death Following Liver Transplantation for Hepatocellular Carcinoma.
Sposito C; Cucchetti A; Mazzaferro V
Dig Dis Sci; 2019 Apr; 64(4):1001-1007. PubMed ID: 30852770
[TBL] [Abstract][Full Text] [Related]
39. Post-transplant infection improves outcome of hepatocellular carcinoma patients after orthotopic liver transplantation.
Chao JS; Zhao SL; Ou-Yang SW; Qian YB; Liu AQ; Tang HM; Zhong L; Peng ZH; Xu JM; Sun HC
World J Gastroenterol; 2019 Oct; 25(37):5630-5640. PubMed ID: 31602163
[TBL] [Abstract][Full Text] [Related]
40. Liver transplantation in the MELD era--analysis of the OPTN/UNOS registry.
Taniguchi M
Clin Transpl; 2012; ():41-65. PubMed ID: 23721009
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
